Literature DB >> 23327622

Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease.

S K Velusamy1, K Ganeshnarayan, K Markowitz, H Schreiner, D Furgang, D H Fine, K Velliyagounder.   

Abstract

BACKGROUND: Among the innate defense mechanisms in the oral cavity, lactoferrin (LF) is a vital antimicrobial that can modify the host response against periodontopathogens. Aggregatibacter actinomycetemcomitans is the main periodontopathogen of localized aggressive periodontitis. The aim of this study is to evaluate the role of LF during A. actinomycetemcomitans-induced periodontitis.
METHODS: Differences in the expression levels of cytokines, chemokines, chemokine receptors, and bone loss markers between wild-type (WT) and LF knockout mice (LFKO(-/-)) were evaluated by real time-PCR. Serum IgG and LF levels were quantified by ELISA. Alveolar bone loss among the groups was estimated by measuring the distance from cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) at 20 molar sites.
RESULTS: Oral infection with A. actinomycetemcomitans increased LF levels in periodontal tissue (P = 0.01) and saliva (P = 0.0004) of wild-type infected (WTI) mice compared to wild-type control mice. Pro-inflammatory cytokines such as interferon-γ, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and IL-12 were increased in the infected LF knockout (LFKO(-/-)I) mice compared to the WTI mice, whereas the anti-inflammatory cytokines IL-4 and IL-10 were decreased. Chemokines and chemokine receptors showed different expression patterns between WTI and LFKO(-/-)I mice. The LFKO(-/-)I mice developed increased bone loss (P = 0.002), in conjunction with increased expression of receptor activator of nuclear factor-κB ligand and decrease in osteoprotegerin, compared to WTI mice.
CONCLUSIONS: These results demonstrate that the infected LFKO(-/-) mice were more susceptible to A. actinomycetemcomitans-induced alveolar bone loss, with different patterns of immune responses compared to those of WTI mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23327622     DOI: 10.1902/jop.2013.120587

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  13 in total

1.  Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice.

Authors:  Lingyu Wei; Xuemei Zhang; Jia Wang; Qiurong Ye; Xiang Zheng; Qiu Peng; Ying Zheng; Peishan Liu; Xiaoyue Zhang; Zhengshuo Li; Can Liu; Qun Yan; Guiyuan Li; Jian Ma
Journal:  Oncogene       Date:  2019-08-28       Impact factor: 9.867

2.  Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice.

Authors:  Senthil Kumar Velusamy; Daniel H Fine; Kabilan Velliyagounder
Journal:  Microbes Infect       Date:  2014-08-11       Impact factor: 2.700

3.  Oral lactoferrin protects against experimental candidiasis in mice.

Authors:  K Velliyagounder; W Alsaedi; W Alabdulmohsen; K Markowitz; D H Fine
Journal:  J Appl Microbiol       Date:  2014-11-25       Impact factor: 3.772

Review 4.  Lactoferrin: A Roadmap to the Borderland between Caries and Periodontal Disease.

Authors:  D H Fine
Journal:  J Dent Res       Date:  2015-03-17       Impact factor: 6.116

5.  NADPH Oxidase Contributes to Resistance against Aggregatibacter actinomycetemcomitans-Induced Periodontitis in Mice.

Authors:  Antje Bast; Helen Kubis; Birte Holtfreter; Silvia Ribback; Heiner Martin; Helen C Schreiner; Malte J Dominik; Katrin Breitbach; Frank Dombrowski; Thomas Kocher; Ivo Steinmetz
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

6.  Diabetic Lactoferrin Deficient Mice Demonstrates Greater Susceptibility to Experimental Periodontal Disease.

Authors:  Waad Alabdulmohsen; Sonia D Rozario; Kenneth Markowitz; Daniel H Fine; Kabilan Velliyagounder
Journal:  J Oral Biol (Northborough)       Date:  2015-07-02

7.  Deficiency of Lactoferrin aggravates lipopolysaccharide-induced acute inflammation via recruitment macrophage in mice.

Authors:  Can Liu; Qiu Peng; Lingyu Wei; Zhengshuo Li; Xiaoyue Zhang; Yangge Wu; Jia Wang; Xiang Zheng; Yuqing Wen; Run Zheng; Qun Yan; Qiurong Ye; Jian Ma
Journal:  Biometals       Date:  2022-06-01       Impact factor: 3.378

8.  Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.

Authors:  Kathryn A Patras; Albert D Ha; Emma Rooholfada; Joshua Olson; Satish P Ramachandra Rao; Ann E Lin; Victor Nizet
Journal:  J Innate Immun       Date:  2019-05-03       Impact factor: 7.349

9.  Protective effects of human lactoferrin during Aggregatibacter actinomycetemcomitans-induced bacteremia in lactoferrin-deficient mice.

Authors:  S K Velusamy; R Poojary; R Ardeshna; Waad Alabdulmohsen; D H Fine; K Velliyagounder
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

10.  Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice.

Authors:  Qiurong Ye; Ying Zheng; Songqing Fan; Zailong Qin; Nan Li; Anliu Tang; Feiyan Ai; Xuemei Zhang; Yanhui Bian; Wei Dang; Jing Huang; Ming Zhou; Yanhong Zhou; Wei Xiong; Qun Yan; Jian Ma; Guiyuan Li
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.